Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization
Details
Publication Year 2023-10-26,Volume 14,Issue #1,Page 6804
Journal Title
Nature Communications
Abstract
The necroptosis pathway is a lytic, pro-inflammatory mode of cell death that is widely implicated in human disease, including renal, pulmonary, gut and skin inflammatory pathologies. The precise mechanism of the terminal steps in the pathway, where the RIPK3 kinase phosphorylates and triggers a conformation change and oligomerization of the terminal pathway effector, MLKL, are only emerging. Here, we structurally identify RIPK3-mediated phosphorylation of the human MLKL activation loop as a cue for MLKL pseudokinase domain dimerization. MLKL pseudokinase domain dimerization subsequently drives formation of elongated homotetramers. Negative stain electron microscopy and modelling support nucleation of the MLKL tetramer assembly by a central coiled coil formed by the extended, ~80 Å brace helix that connects the pseudokinase and executioner four-helix bundle domains. Mutational data assert MLKL tetramerization as an essential prerequisite step to enable the release and reorganization of four-helix bundle domains for membrane permeabilization and cell death.
Publisher
NPG
Keywords
Humans; Phosphorylation; Necrosis; *Protein Kinases/metabolism; Dimerization; Cell Death; *Receptor-Interacting Protein Serine-Threonine Kinases/metabolism; Apoptosis
Research Division(s)
Inflammation; Advanced Technology And Biology; Structural Biology
PubMed ID
37884510
Open Access at Publisher's Site
https://doi.org/10.1038/s41467-023-42255-w
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-11-15 05:00:14
Last Modified: 2023-11-15 05:33:17
An error has occurred. This application may no longer respond until reloaded. Reload 🗙